How many institutions held BTCY - BIOTRICITY INC. - Common Stock, par value $0.001 per share in Q3 2025?

1 institutional investor reported BTCY - BIOTRICITY INC. - Common Stock, par value $0.001 per share for Q3 2025. Use the holders table for investor-level position and value details.

BIOTRICITY INC. - Common Stock, par value $0.001 per share (BTCY)

Q: What does CUSIP 09074H203 represent in this 13F holders report?

CUSIP 09074H203 is the security identifier for BTCY - BIOTRICITY INC. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

CUSIP: 09074H203

Q3 2025 13F Holders as of 30 Sep 2025

Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 30,666,263
Total 13F shares: 48,263
Share change: +48,263
Total reported value: $25,579
Price per share: $0.53
Number of holders: 1
Value change: +$25,579
Number of buys: 1

Quarterly Holders Quick Answers

What is CUSIP 09074H203?
CUSIP 09074H203 identifies BTCY - BIOTRICITY INC. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q4 2025
Previous quarter: Q4 2024

Recent filing periods for CUSIP 09074H203:

Q4 2025 Q3 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023

Top shareholders of BTCY - BIOTRICITY INC. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Norman M. Betts	3/4/5	Director	— class O/S missing	375,598	$1,145,574	—	29 Nov 2021	3/4/5
Waqaas Al-Siddiq	3/4/5	President, CEO and Chairman, Director	— class O/S missing	4,899,984	—	—	12 Mar 2023	3/4/5
John Ayanoglou	3/4/5	Chief Financial Officer	— class O/S missing	1,328,488	—	—	26 Oct 2017	3/4/5
David A. Rosa	3/4/5	Director	— class O/S missing	474,683	—	—	12 Mar 2023	3/4/5

Institutional Holders of BIOTRICITY INC. - Common Stock, par value $0.001 per share (BTCY) as of Q3 2025

As of 30 Sep 2025, BIOTRICITY INC. - Common Stock, par value $0.001 per share (BTCY) was held by 1 institutional shareholder that filed Form 13F with the SEC. Together, they reported ownership of 48,263 shares. The largest 1 holders included Strengthening Families & Communities, LLC. This page lists 1 institutional shareholders reporting positions in this security for the Q3 2025 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q3 2025 vs Q4 2024 Across Filers

Q4 2024 holders

Q3 2025 holders

Holder diff

Investor	Q4 2024 Shares	Q3 2025 Shares	Share Diff	Share Chg %	Q4 2024 Value $	Q3 2025 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.